Organogenesis Holdings Inc (ORGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | ||
| Net Income | -7,525 | -14,766 |
| Depreciation Amortization | 5,628 | 7,319 |
| Other Working Capital | -5,268 | -7,397 |
| Other Operating Activity | 3,591 | 9,973 |
| Operating Cash Flow | $-3,574 | $-4,871 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -2,418 | -1,246 |
| Net Acquisitions | -11,790 | 0 |
| Other Investing Activity | -666 | 0 |
| Investing Cash Flow | $-14,874 | $-1,246 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 18,948 | 6,776 |
| Financing Cash Flow | $18,948 | $6,776 |
| Beginning Cash Position | 1,858 | 1,199 |
| End Cash Position | 2,358 | 1,858 |
| Net Cash Flow | $500 | $659 |
| Free Cash Flow | ||
| Operating Cash Flow | -3,574 | -4,871 |
| Free Cash Flow | -3,574 | -4,871 |